Abstract
The human receptors for insulin-like growth factor 1 (IGF-1) and insulin, and two chimeric receptors consisting of ligand-binding, extracellular insulin receptor and intracellular IGF-1 receptor structures, have been expressed in NIH-3T3 fibroblasts. All four receptor types were synthesized, processed and transported to the cell surface to form high-affinity binding sites. All normal and chimeric receptors had an active tyrosine kinase which was regulated by homologous or heterologous ligands respectively. In addition, cell surface receptors were internalized efficiently and subjected to accelerated degradation in the presence of ligand. While all four types of receptor stimulated glucose transport with similar efficiency, they displayed significant differences in their mitogenic signalling potentials. Receptors with an IGF-1 receptor cytoplasmic domain were 10 times more active in stimulating DNA synthesis than the insulin receptor. In NIH-3T3 cells overexpressing wild-type and chimeric receptors, maximal growth responses obtained with IGF-1 or insulin alone were equivalent to those obtained with 10% fetal calf serum. We conclude that in the cell system employed the receptors for IGF-1 and insulin mediate short-term responses similarly, but display distinct characteristics in their long-term mitogenic signalling potentials.
MeSH Terms
Animals
Biological Transport, Active
Cells, Cultured
Cytoplasm/metabolism
Endocytosis
Glucose/metabolism
Humans
Insulin-Like Growth Factor I/metabolism
Kinetics
Mitogens
Phosphorylation
Receptor, Insulin/metabolism
Receptors, Cell Surface/metabolism
Receptors, Somatomedin
Recombinant Proteins/metabolism
Signal Transduction
Chemicals
Mitogens
Receptors, Cell Surface
Receptors, Somatomedin
Recombinant Proteins
Insulin-Like Growth Factor I
Receptor, Insulin
Glucose
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lammers R
Department of Developmental Biology, Genetech, Inc., South San Francisco, CA 94080.
Gray A
Schlessinger J
Ullrich A
References (24)
24 references, click to expand
-
The molecular mechanism of insulin action.
Annu Rev Med. 1985;36:429-51
PMID: 2986528
-
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.
Nature. 1985 Feb 28-Mar 6;313(6005):756-61
PMID: 2983222
-
Actions of insulin-like growth factors.
Annu Rev Physiol. 1985;47:443-67
PMID: 2986538
-
Regulation by growth hormone of number of chondrocytes containing IGF-I in rat growth plate.
Science. 1986 Aug 1;233(4763):571-4
PMID: 3523759
-
Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.
EMBO J. 1986 Oct;5(10):2503-12
PMID: 2877871
-
A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor.
Nature. 1986 Nov 6-12;324(6092):68-70
PMID: 3024008
-
Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.
J Biol Chem. 1987 Feb 5;262(4):1842-7
PMID: 3100537
-
Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity.
Proc Natl Acad Sci U S A. 1987 Feb;84(3):704-8
PMID: 3101064
-
The insulin receptor concept and its relation to the treatment of diabetes.
Drugs. 1987 Feb;33(2):156-70
PMID: 3552593
-
An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.
Proc Natl Acad Sci U S A. 1987 May;84(10):3254-8
PMID: 2953025
-
Insulin-like and insulin-inhibitory effects of monoclonal antibodies for different epitopes on the human insulin receptor.
Biochem J. 1987 Feb 15;242(1):123-9
PMID: 2439067
-
The protein-tyrosine kinase activity of the insulin receptor is necessary for insulin-mediated receptor down-regulation.
J Biol Chem. 1987 Aug 25;262(24):11833-40
PMID: 2957374
-
A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.
J Biol Chem. 1987 Oct 25;262(30):14663-71
PMID: 3312193
-
Receptor binding and mitogenic effects of insulin and insulinlike growth factors I and II for human myeloid leukemic cells.
J Cell Physiol. 1987 Nov;133(2):219-27
PMID: 2960684
-
Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts.
Proc Natl Acad Sci U S A. 1988 Mar;85(5):1477-81
PMID: 3257824
-
Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line.
Cancer Res. 1988 Jul 1;48(13):3716-9
PMID: 3378214
-
Molecular analysis of signal transduction by growth factors.
Biochemistry. 1988 May 3;27(9):3113-9
PMID: 3291942
-
Expression and characterization of a functional human insulin-like growth factor I receptor.
J Biol Chem. 1988 Aug 15;263(23):11486-92
PMID: 2969892
-
Ligand-receptor interactions involved in the stimulation of Swiss 3T3 fibroblasts by insulin-like growth factors and insulin.
Biochem J. 1988 May 15;252(1):119-25
PMID: 2971349
-
Growth factor receptor tyrosine kinases.
Annu Rev Biochem. 1988;57:443-78
PMID: 3052279
-
A new technique for the assay of infectivity of human adenovirus 5 DNA.
Virology. 1973 Apr;52(2):456-67
PMID: 4705382
-
Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells.
J Biol Chem. 1980 Feb 25;255(4):1239-41
PMID: 6243633
-
Monoclonal antibodies to receptors for insulin and somatomedin-C.
J Biol Chem. 1983 May 25;258(10):6561-6
PMID: 6304046
-
The nature and regulation of the receptors for insulin-like growth factors.
Annu Rev Physiol. 1985;47:425-42
PMID: 2986537